Our attorneys frequently author or co-author articles, memoranda and newsletters. Please click here if you would like to receive a copy of any of these publications.
January 2015 | Skadden's 2015 Insights
The increased M&A activity that began in late 2013 continued to mount last year, bringing deal volume and total transactions to their highest levels since before the global financial crisis. Although the pace of the economic recovery varies significantly from region to region, key drivers of M&A activity remain in place heading into 2015.
January 20, 2015 | Skadden, Arps, Slate, Meagher & Flom LLP | Daniel A. DeVito, James J. Elacqua, David W. Hansen, Douglas R. Nemec, P. Anthony Sammi, James F. Brelsford, Stacey L. Cohen, Devin A. Kothari
In a 7-2 decision issued on January 20, 2015, the U.S. Supreme Court, in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., held that the Federal Circuit must review factual findings underlying claim construction for clear error, pursuant to Federal Rule of Civil Procedure 52(a)(6). The decision to provide deference to the “evidentiary underpinnings” of district courts’ claim construction rulings makes clear that factual determinations in patent cases should not be treated differently than those in other areas of the law. The ruling also will provide more certainty in instances where a lower court’s claim construction is based, in part, on extrinsic evidence.
January 2015 | Skadden's 2015 Insights - Global Litigation | Filipe B. Areno, Gary DiBianco, Bradley A. Klein, Anke C. Sessler, Jocelyn E. Strauber, J. Mathias von Bernuth, Gregoire Bertrou, Matthew CowieIn the global criminal and regulatory enforcement arena, robust enforcement actions against multinational companies are likely to continue worldwide in 2015. In North and South America, Europe and Asia, with criminal investigations and prosecutions across multiple areas, regulators are working...